Evidence map›Paper›PMID 41514624›Full record

ArticleCancers2025

Therapy-Induced Neutropenia and Poor Prognosis in Patients with Locally Advanced Esophageal Cancer Who Underwent Concurrent Chemoradiotherapy with Docetaxel, Cisplatin, and 5-Fluorouracil.

Makoto Sakai, Nobuhiro Nakazawa, Kengo Kuriyama, Takuhisa Okada, Takuya Shiraishi, Yuji Kumakura, Akiharu Kimura, Akihiko Sano, Takehiko Yokobori, Ken Shirabe and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Makoto SakaiDepartment of General Surgical Science, Graduate School of Medicine, Gunma University, Maebashi 371-8511, Japan.ORCID 0000-0003-0860-3132
Nobuhiro NakazawaDepartment of General Surgical Science, Graduate School of Medicine, Gunma University, Maebashi 371-8511, Japan.
Kengo KuriyamaDepartment of General Surgical Science, Graduate School of Medicine, Gunma University, Maebashi 371-8511, Japan.
Takuhisa OkadaDepartment of General Surgical Science, Graduate School of Medicine, Gunma University, Maebashi 371-8511, Japan.
Takuya ShiraishiDepartment of General Surgical Science, Graduate School of Medicine, Gunma University, Maebashi 371-8511, Japan.
Yuji KumakuraDepartment of General Surgical Science, Graduate School of Medicine, Gunma University, Maebashi 371-8511, Japan.
Akiharu KimuraDepartment of General Surgical Science, Graduate School of Medicine, Gunma University, Maebashi 371-8511, Japan.ORCID 0000-0002-6832-4146
Akihiko SanoDepartment of General Surgical Science, Graduate School of Medicine, Gunma University, Maebashi 371-8511, Japan.
Takehiko YokoboriDivision of Gene Therapy Science, Initiative for Advanced Research (GIAR), Gunma University, Maebashi 371-8511, Japan.ORCID 0000-0003-3284-4796
Ken ShirabeDepartment of General Surgical Science, Graduate School of Medicine, Gunma University, Maebashi 371-8511, Japan.
Hiroshi SaekiDepartment of General Surgical Science, Graduate School of Medicine, Gunma University, Maebashi 371-8511, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

chemoradiotherapyesophageal cancerneutropeniaoverall survival

Identifiers

PMID41514624
PMCPMC12785004

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.